The global R&D and application base for stem cell storage has been inaugurated in Gaochun district of Nanjing to be developed into a high-tech life science research base integrating stem cell storage, drug development, and medical applications.
The use of stem cells to treat diseases is one of the cutting-edge directions in medical research today.
The global R&D and application base for stem cell storage is located in the Gaochun Economic Development Zone, Nanjing. Being the core project of Nanjing to build a high-end biopharmaceutical industrial cluster, the base can store 3 million oral stem cells and umbilical cord stem cells, complete with a stem cell production workshop, a quality inspection center, and an R&D center for international cooperation.
At present, a number of researches on the clinical application of stem cells have been conducted at home and abroad, concerning the treatment of various diseases including arthritis, cirrhosis, diabetes, and lupus erythematosus.
Experts said that China has gradually shown its own advantages in the field of stem cell research, although developed countries in Europe and the USA, Japan and South Korea started earlier.
With the implementation of the "Healthy China" plan in China, stem cell medical research has received more and more attention. Nanjing is accelerating its deployment of the Greater Health Plan as part of its future industry by gathering such industries as stem cells, genes, and medical devices to attract a large number of experts from universities and research institutions.
